Hepatocellular Carcinoma Risk Persists in Patients With HCV-Related Cirrhosis
07/19/2021
Michael Banks, MD, discusses the risk for cirrhosis regression and liver cancer in patients with HCV-related cirrhosis who have already achieved sustained virologic response via direct-acting antiviral treatment.
Additional Resources:
The Doctor's Channel.